Trial intelligence / Profile preview

Paracetamol vs Ibuprofen for PDA Closure in Preterm Neonates

NCT06152796Phase 2Not yet recruiting

Sponsor
Assiut University
Start
Dec 2023
Primary completion
Sep 2025
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Assiut University. Primary endpoint: Closure of Patent Ductus Arteriosus at 6 days. Planned start Dec 2023; status: not yet recruiting.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on NCT06152796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06152796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call